Equity Overview
Price & Market Data
Price: $3.53
Daily Change: -$0.27 / 7.65%
Daily Range: $3.35 - $3.90
Market Cap: $131,280,864
Daily Volume: 110,756
Performance Metrics
1 Week: 8.10%
1 Month: 3.58%
3 Months: -13.90%
6 Months: -44.03%
1 Year: -42.00%
YTD: -37.81%
Company Details
Employees: 136
Sector: Health technology
Industry: Medical specialties
Country:
Details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.